Vitamin D prescribing in children in UK primary care practices: a population-based cohort study

Mandy Wan1,2, Laura J Horsfall3, Emre Basatemur4

  • 1Evelina Pharmacy, Guy's and Saint Thomas' NHS Foundation Trust, London, UK Mandy.Wan@gstt.nhs.uk.

BMJ Open
|December 5, 2019
PubMed

Insights

Vitamin D prescribing in UK children surged 26-fold from 2008-2016. General practitioners (GPs) often deviated from national guidelines, with inconsistent dosing and lack of blood tests.

Area of Science:

  • Pediatric Endocrinology
  • Public Health
  • General Practice

Background:

  • Vitamin D supplementation is crucial for pediatric bone health and overall well-being.
  • Understanding prescribing patterns in primary care is essential for guideline adherence and resource allocation.
  • Previous trends in pediatric vitamin D supplementation in the UK remain incompletely characterized.

Purpose of the Study:

  • To analyze temporal trends in the incidence and patterns of vitamin D prescribing by UK general practitioners (GPs) for children (0-17 years) between 2008 and 2016.
  • To investigate sociodemographic factors associated with vitamin D prescribing rates.
  • To evaluate the adherence to national guidelines regarding supplementation regimens, dosage, and the use of 25-hydroxyvitamin D (25(OH)D) testing.

Main Methods:

  • A population-based cohort study utilizing UK general practice records from The Health Improvement Network (THIN).
  • Annual incidence rates of vitamin D prescriptions were calculated and analyzed using multivariable Poisson regression.
  • Detailed analysis of supplementation type, dose, dosing schedule, linked 25(OH)D laboratory results, and clinical symptoms.

Main Results:

  • A 26-fold increase in the crude annual incidence of vitamin D prescribing was observed, rising from 10.8 to 276.8 per 100,000 person-years between 2008 and 2016.
  • Higher prescribing rates were associated with older children, non-white ethnicity, and practices in England.
  • Inconsistent supplementation regimens were noted, with a significant proportion of prescriptions lacking pre-supplementation 25(OH)D levels (28.7%-56.4%) and increasing use of pharmacological doses, often deviating from UK recommendations.

Conclusions:

  • A substantial and sustained rise in vitamin D supplementation prescribing for children has occurred in UK primary care.
  • General practitioners (GPs) demonstrated inconsistent adherence to national guidelines for vitamin D supplementation in pediatric care.
  • Further research and clearer guidance are needed to ensure optimal and evidence-based vitamin D prescribing practices for children.
Abstract

Related Concept Videos

Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
7.4K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
215
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
4.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
200
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
120
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
177